Related references
Note: Only part of the references are listed.Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury
Sandy R. Shultz et al.
BRAIN (2015)
Methodological considerations on tract-based spatial statistics (TBSS)
Michael Bach et al.
NEUROIMAGE (2014)
Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models
Nigel C. Jones et al.
NEUROBIOLOGY OF DISEASE (2012)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau et al.
NEUROBIOLOGY OF AGING (2011)
Avoiding asymmetry-induced bias in longitudinal image processing
Martin Reuter et al.
NEUROIMAGE (2011)
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
N. M. Corcoran et al.
BRITISH JOURNAL OF CANCER (2010)
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
Janet van Eersel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference
Stephen M. Smith et al.
NEUROIMAGE (2009)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Confidence intervals for standardized linear contrasts of means
Douglas G. Bonett
PSYCHOLOGICAL METHODS (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Disease-modifying trials in Alzheimer's disease: a European task force consensus
Bruno Vellas et al.
LANCET NEUROLOGY (2007)
Principles of diffusion tensor imaging and its applications to basic neuroscience research
Susumu Mori et al.
NEURON (2006)
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
Stephen M. Smith et al.
NEUROIMAGE (2006)
Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum
SW Sun et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
Higher atrophy rate of entorhinal cortex than hippocampus in AD
AT Du et al.
NEUROLOGY (2004)
Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia
SK Song et al.
NEUROIMAGE (2003)
Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease
CX Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
